NASDAQ 100 Leads Tech Rally as Major Indexes Climb on US-China Tariff Easing

3 min read | May 13, 2025 07:02 AM PDT | By Team Kalkine Media

Highlights:

  • US indexes closed significantly higher following a mutual tariff rollback between the US and China

  • Technology and semiconductor stocks surged, with NVDA, AMZN, and TSLA among notable gainers

  • Upcoming inflation and retail data scheduled later in the week could reflect early impacts of tariff shifts

Technology stocks rallied sharply at the start of the week, lifting key benchmarks including the S&P 500, Dow Jones Industrial Average, and NASDAQ 100. This performance followed an announcement by the United States and China to implement a reciprocal rollback of tariffs for a defined period. The move alleviated immediate trade concerns, contributing to broad gains across sectors, with tech leading the session’s momentum.

Nvidia Corporation (NVDA), a major player in the artificial intelligence semiconductor space, moved upward as enthusiasm returned to the segment. Amazon.com Inc. (AMZN), Apple Inc. (AAPL), and Tesla Inc. (TSLA) also climbed, contributing to the advance of tech-weighted indexes.

Dow Jones Industrial Average, S&P 500, and NASDAQ 100 each advanced during the session, marking a strong return to risk-on sentiment. These gains aligned with price movements across major tech constituents, a segment previously subdued by trade dispute uncertainty.

Tariff Rollback Triggers Market-Wide Lift

The rollback terms outlined reductions in duties on a large range of goods exchanged between the two nations. The United States adjusted tariffs on Chinese goods to lower levels, while China made similar reductions for American imports. This agreement will be in place for a specific duration, with both sides monitoring conditions during the period.

This development led to accelerated buying activity in the session, particularly within large-cap stocks that had experienced volatility due to prolonged trade tensions. The announcement had a pronounced impact on semiconductors and hardware manufacturers, where revenue exposure to overseas markets is typically high.

Among the day’s leaders, Amazon.com Inc. (AMZN) and Tesla Inc. (TSLA) gained ground alongside Meta Platforms Inc. (META) and Microsoft Corporation (MSFT), with communication services and information technology sectors among the day’s top performers.

Currency and Commodities Reaction

The US dollar index (DX=F) strengthened during the session, aligning with increased demand for US-based assets. US Treasury yields (10-year: ^TNX) moved higher as bond markets responded to expectations of changing macroeconomic conditions.

In commodities, oil benchmarks including West Texas Intermediate (CL=F) and Brent Crude (BZ=F) pushed higher, reflecting global optimism and enhanced trade flow outlooks. This movement contributed to sector-specific rallies in energy and materials.

Upcoming Economic Reports in Focus

Market participants will receive updated economic data over the coming days. April's Consumer Price Index (CPI) is scheduled for release, offering a look into consumer-level price changes. This will be followed by retail sales data and the Producer Price Index (PPI), which could provide insight into wholesale pricing and consumer spending behavior.

These reports may offer clarity on how recent trade policy shifts are impacting domestic inflation and consumption patterns. Pharmaceutical and consumer sectors will be closely watched as government directives on drug pricing and consumer demand evolve in parallel.

Pharmaceutical Developments Influence Sector Outlook

In related policy news, the White House issued an executive directive aimed at altering the pricing structure of pharmaceutical goods within the domestic market. While designed to reduce pricing for US consumers, commentary indicated that international pricing structures may adjust, which could shift revenue sources for major pharmaceutical firms.

The directive’s implications were observed in healthcare sector activity, with pricing reforms expected to influence earnings dynamics across global markets. Companies operating in biotechnology and life sciences industries saw varied performance, with several names responding to news coverage of the announcement.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.


Sponsored Articles


Investing Ideas

Previous Next